Amedeo Smart

Free Medical Literature Service


 

Amedeo

Gastric Cancer

  Free Subscription

Articles published in
BMC Cancer
    August 2021
  1. CHEN L, Zhang C, Yao Z, Cui M, et al
    Adjuvant chemotherapy is an additional option for locally advanced gastric cancer after radical gastrectomy with D2 lymphadenectomy: a retrospective control study.
    BMC Cancer. 2021;21:974.
    >> Share

  2. LI HQ, Xue H, Yuan H, Wan GY, et al
    Preferences of first-degree relatives of gastric cancer patients for gastric cancer screening: a discrete choice experiment.
    BMC Cancer. 2021;21:959.
    >> Share

  3. NING G, Zhu Q, Kang W, Lee H, et al
    A novel treatment strategy for lapatinib resistance in a subset of HER2-amplified gastric cancer.
    BMC Cancer. 2021;21:923.
    >> Share

  4. WANG J, Xu P, Hao Y, Yu T, et al
    Interaction between DNMT3B and MYH11 via hypermethylation regulates gastric cancer progression.
    BMC Cancer. 2021;21:914.
    >> Share

    July 2021
  5. YEN CC, Shan YS, Chao YJ, Liao TK, et al
    Surgery alone, adjuvant tegafur/gimeracil/octeracil (S-1), or platinum-based chemotherapies for resectable gastric cancer: real-world experience and a propensity score matching analysis.
    BMC Cancer. 2021;21:796.
    >> Share

    June 2021
  6. SANTERO M, Perez-Bracchiglione J, Acosta-Dighero R, Meade AG, et al
    Efficacy of systemic oncological treatments in patients with advanced esophageal or gastric cancers at high risk of dying in the middle and short term: an overview of systematic reviews.
    BMC Cancer. 2021;21:712.
    >> Share

  7. YE Z, Zeng Y, Wei S, Wang Y, et al
    Short-term survival and safety of apatinib combined with oxaliplatin and S-1 in the conversion therapy of unresectable gastric cancer.
    BMC Cancer. 2021;21:702.
    >> Share

  8. LU XQ, Zhang JQ, Zhang SX, Qiao J, et al
    Identification of novel hub genes associated with gastric cancer using integrated bioinformatics analysis.
    BMC Cancer. 2021;21:697.
    >> Share

  9. WU R, Guo S, Lai S, Pan G, et al
    A stable gene set for prediction of prognosis and efficacy of chemotherapy in gastric cancer.
    BMC Cancer. 2021;21:684.
    >> Share

  10. ZHANG J, Lv W, Liu Y, Fu W, et al
    LINC_00355 promotes gastric cancer progression by upregulating PHF19 expression through sponging miR-15a-5p.
    BMC Cancer. 2021;21:657.
    >> Share

    May 2021
  11. DAI J, Nishi A, Li ZX, Zhang Y, et al
    DNA methylation signatures associated with prognosis of gastric cancer.
    BMC Cancer. 2021;21:610.
    >> Share

  12. CHEN Y, Hu N, Liao L, Yu K, et al
    ABO genotypes and the risk of esophageal and gastric cancers.
    BMC Cancer. 2021;21:589.
    >> Share

  13. CHUN SH, Kim EY, Yoon JS, Won HS, et al
    Prognostic value of noggin protein expression in patients with resected gastric cancer.
    BMC Cancer. 2021;21:558.
    >> Share

  14. NIE C, Han X, Wei R, Leonteva A, et al
    Association of ZNF331 and WIF1 methylation in peripheral blood leukocytes with the risk and prognosis of gastric cancer.
    BMC Cancer. 2021;21:551.
    >> Share

    April 2021
  15. LIU N, Wu Y, Cheng W, Wu Y, et al
    Identification of novel prognostic biomarkers by integrating multi-omics data in gastric cancer.
    BMC Cancer. 2021;21:460.
    >> Share

  16. ZHONG X, Xuan F, Qian Y, Pan J, et al
    A genomic-clinicopathologic Nomogram for the preoperative prediction of lymph node metastasis in gastric cancer.
    BMC Cancer. 2021;21:455.
    >> Share

  17. LIU L, Zhang C, Wang J, Liu X, et al
    A high level of lncFGD5-AS1 inhibits epithelial-to-Mesenchymal transition by regulating the miR-196a-5p/SMAD6/BMP axis in gastric Cancer.
    BMC Cancer. 2021;21:453.
    >> Share

  18. YU J, Jung J, Park SR, Ryu MH, et al
    Role of palliative radiotherapy in bleeding control in patients with unresectable advanced gastric cancer.
    BMC Cancer. 2021;21:413.
    >> Share

  19. YU Y, Xie Z, Zhao M, Lian X, et al
    Identification of PIK3CA multigene mutation patterns associated with superior prognosis in stomach cancer.
    BMC Cancer. 2021;21:368.
    >> Share

    March 2021
  20. KIM TH, Do Cho H, Choi YW, Lee HW, et al
    Trastuzumab-based palliative chemotherapy for HER2-positive gastric cancer: a single-center real-world data.
    BMC Cancer. 2021;21:325.
    >> Share

  21. CAI Z, Song H, Fingerhut A, Sun J, et al
    A greater lymph node yield is required during pathological examination in microsatellite instability-high gastric cancer.
    BMC Cancer. 2021;21:319.
    >> Share

  22. LIANG Y, Zhao L, Chen H, Lin T, et al
    Correction to: Survival analysis of elderly patients over 65 years old with stage II/III gastric cancer treated with adjuvant chemotherapy after laparoscopic D2 gastrectomy: a retrospective cohort study.
    BMC Cancer. 2021;21:298.
    >> Share

  23. JI J, Chen J, Wang A, Zhang W, et al
    KK-LC-1 may be an effective prognostic biomarker for gastric cancer.
    BMC Cancer. 2021;21:267.
    >> Share

  24. SATO A, Matsubayashi K, Morishima T, Nakata K, et al
    Increasing trends in the prevalence of prior cancer in newly diagnosed lung, stomach, colorectal, breast, cervical, and corpus uterine cancer patients: a population-based study.
    BMC Cancer. 2021;21:264.
    >> Share

  25. HE P, Cheng S, Hu F, Ma Z, et al
    Up-regulation of DGAT1 in cancer tissues and tumor-infiltrating macrophages influenced survival of patients with gastric cancer.
    BMC Cancer. 2021;21:252.
    >> Share

  26. GE Y, Wei F, Du G, Fei G, et al
    The association of sex-biased ATRX mutation in female gastric cancer patients with enhanced immunotherapy-related anticancer immunity.
    BMC Cancer. 2021;21:240.
    >> Share

  27. OKAGAWA Y, Sumiyoshi T, Kondo H, Tomita Y, et al
    Comparison of clinicopathological features and long-term prognosis between mixed predominantly differentiated-type and pure differentiated-type early gastric cancer.
    BMC Cancer. 2021;21:235.
    >> Share

  28. EHARA T, Uehara T, Nakajima T, Kinugawa Y, et al
    LGR5 expression is associated with prognosis in poorly differentiated gastric adenocarcinoma.
    BMC Cancer. 2021;21:228.
    >> Share

  29. FAN B, Bu Z, Zhang J, Zong X, et al
    Phase II trial of prophylactic hyperthermic intraperitoneal chemotherapy in patients with locally advanced gastric cancer after curative surgery.
    BMC Cancer. 2021;21:216.
    >> Share

  30. LIM JH, Song JH, Chung SJ, Chung GE, et al
    Characteristics of interval gastric neoplasms detected within two years after negative screening endoscopy among Koreans.
    BMC Cancer. 2021;21:218.
    >> Share

    February 2021
  31. LIANG Y, Zhao L, Chen H, Lin T, et al
    Survival analysis of elderly patients over 65 years old with stage II/III gastric cancer treated with adjuvant chemotherapy after laparoscopic D2 gastrectomy: a retrospective cohort study.
    BMC Cancer. 2021;21:196.
    >> Share

  32. CHEN XJ, Chen GM, Wei YC, Yu H, et al
    Palliative Gastrectomy versus Gastrojejunostomy for advanced Gastric cancer with outlet obstruction: a propensity score matching analysis.
    BMC Cancer. 2021;21:188.
    >> Share

  33. KIM KW, Lee K, Lee JB, Park T, et al
    Preoperative nutritional risk index and postoperative one-year skeletal muscle loss can predict the prognosis of patients with gastric adenocarcinoma: a registry-based study.
    BMC Cancer. 2021;21:157.
    >> Share

  34. BAEG K, Harris C, Naparst MS, Ahn E, et al
    Effect of treatment center volume on outcomes in gastroenteropancreatic neuroendocrine tumor patients.
    BMC Cancer. 2021;21:146.
    >> Share

    January 2021
  35. ITO A, Kagawa S, Sakamoto S, Kuwada K, et al
    Extracellular vesicles shed from gastric cancer mediate protumor macrophage differentiation.
    BMC Cancer. 2021;21:102.
    >> Share

  36. OKUBO K, Arigami T, Matsushita D, Kijima T, et al
    Clinical impact of creatine phosphokinase and c-reactive protein as predictors of postgastrectomy complications in patients with gastric cancer.
    BMC Cancer. 2021;21:95.
    >> Share

  37. EMBAYE KS, Zhang C, Ghebrehiwet MA, Wang Z, et al
    Clinico-pathologic determinants of non-e-curative outcome following en-bloc endoscopic submucosal dissection in patients with early gastric neoplasia.
    BMC Cancer. 2021;21:92.
    >> Share

  38. CHENG X, Wu D, Xu N, Chen L, et al
    Adjuvant albumin-bound paclitaxel combined with S-1 vs. oxaliplatin combined with capecitabine after D2 gastrectomy in patients with stage III gastric adenocarcinoma: a phase III multicenter, open-label, randomized controlled clinical trial protocol.
    BMC Cancer. 2021;21:56.
    >> Share

  39. TONG Y, Zhao Y, Shan Z, Zhang J, et al
    CA724 predicts overall survival in locally advanced gastric cancer patients with neoadjuvant chemotherapy.
    BMC Cancer. 2021;21:4.
    >> Share

  40. TAO S, Gu J, Wang Q, Zheng L, et al
    Translational control of Bcl-2 promotes apoptosis of gastric carcinoma cells.
    BMC Cancer. 2021;21:12.
    >> Share

  41. WANG X, Li S, Sun Y, Li K, et al
    The protocol of a prospective, multicenter, randomized, controlled phase III study evaluating different cycles of oxaliplatin combined with S-1 (SOX) as neoadjuvant chemotherapy for patients with locally advanced gastric cancer: RESONANCE-II trial.
    BMC Cancer. 2021;21:20.
    >> Share

  42. SMITH-PALMER J, Leeuwenkamp OR, Virk J, Reed N, et al
    Lutetium oxodotreotide ((177)Lu-Dotatate) for the treatment of unresectable or metastatic progressive gastroenteropancreatic neuroendocrine tumors: a cost-effectiveness analysis for Scotland.
    BMC Cancer. 2021;21:10.
    >> Share

    November 2020
  43. EBERT K, Zwingenberger G, Barbaria E, Keller S, et al
    Correction to: Determining the effects of trastuzumab, cetuximab and afatinib by phosphoprotein, gene expression and phenotypic analysis in gastric cancer cell lines.
    BMC Cancer. 2020;20:1127.
    >> Share

  44. YU P, Ye Z, Dai G, Zhang Y, et al
    Neoadjuvant systemic and hyperthermic intraperitoneal chemotherapy combined with cytoreductive surgery for gastric cancer patients with limited peritoneal metastasis: a prospective cohort study.
    BMC Cancer. 2020;20:1108.
    >> Share

  45. WU R, Yang C, Ji L, Fan ZN, et al
    Prevalence of gastric cancer precursors in gastroscopy-screened adults by family history of gastric cancer and of cancers other than gastric.
    BMC Cancer. 2020;20:1110.
    >> Share

  46. OKUNAKA M, Kotani D, Demachi K, Kawazoe A, et al
    Retrospective cohort study of nanoparticle albumin-bound paclitaxel plus ramucirumab versus paclitaxel plus ramucirumab as second-line treatment in patients with advanced gastric cancer.
    BMC Cancer. 2020;20:1111.
    >> Share

  47. MASUI T, Ito T, Komoto I, Uemoto S, et al
    Recent epidemiology of patients with gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) in Japan: a population-based study.
    BMC Cancer. 2020;20:1104.
    >> Share

    October 2020
  48. EBERT K, Zwingenberger G, Barbaria E, Keller S, et al
    Determining the effects of trastuzumab, cetuximab and afatinib by phosphoprotein, gene expression and phenotypic analysis in gastric cancer cell lines.
    BMC Cancer. 2020;20:1039.
    >> Share

  49. FUJIMORI D, Kinoshita J, Yamaguchi T, Nakamura Y, et al
    Established fibrous peritoneal metastasis in an immunocompetent mouse model similar to clinical immune microenvironment of gastric cancer.
    BMC Cancer. 2020;20:1014.
    >> Share

  50. WANG JB, Xue Z, Lu J, He QL, et al
    Effect of sarcopenia on short- and long-term outcomes in patients with gastric neuroendocrine neoplasms after radical gastrectomy: results from a large, two-institution series.
    BMC Cancer. 2020;20:1002.
    >> Share

  51. XUE X, Huang J, Yu K, Chen X, et al
    YB-1 transferred by gastric cancer exosomes promotes angiogenesis via enhancing the expression of angiogenic factors in vascular endothelial cells.
    BMC Cancer. 2020;20:996.
    >> Share

    September 2020
  52. SONKAR C, Verma T, Chatterji D, Jain AK, et al
    Status of kinases in Epstein-Barr virus and Helicobacter pylori Coinfection in gastric Cancer cells.
    BMC Cancer. 2020;20:925.
    >> Share

  53. LORENZEN S, Biederstadt A, Ronellenfitsch U, Reissfelder C, et al
    RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomized phase III joint study of the AIO, ARO and DGAV.
    BMC Cancer. 2020;20:886.
    >> Share

  54. JIN X, Dai L, Ma Y, Wang J, et al
    Homeobox proteins are potential biomarkers and therapeutic targets in gastric cancer: a systematic review and meta-analysis.
    BMC Cancer. 2020;20:866.
    >> Share

  55. YOON JY, Brezden-Masley C, Streutker CJ
    Lgr5 and stem/progenitor gene expression in gastric/gastroesophageal junction carcinoma - significance of potentially retained stemness.
    BMC Cancer. 2020;20:860.
    >> Share

    August 2020
  56. ZHU L, Xu Z, Wu Y, Liu P, et al
    Prophylactic chemotherapeutic hyperthermic intraperitoneal perfusion reduces peritoneal metastasis in gastric cancer: a retrospective clinical study.
    BMC Cancer. 2020;20:827.
    >> Share

  57. ZHENG Z, Yin J, Li Z, Ye Y, et al
    Protocol for expanded indications of endoscopic submucosal dissection for early gastric cancer in China: a multicenter, ambispective, observational, open-cohort study.
    BMC Cancer. 2020;20:801.
    >> Share

  58. LEERS JM, Knepper L, van der Veen A, Schroder W, et al
    The CARDIA-trial protocol: a multinational, prospective, randomized, clinical trial comparing transthoracic esophagectomy with transhiatal extended gastrectomy in adenocarcinoma of the gastroesophageal junction (GEJ) type II.
    BMC Cancer. 2020;20:781.
    >> Share

  59. CHEN J, Wang A, Ji K, Bu Z, et al
    Comparison of overall survival of gastric neoplasms containing neuroendocrine carcinoma components with gastric adenocarcinoma: a propensity score matching study.
    BMC Cancer. 2020;20:777.
    >> Share

  60. JIANG H, Zheng Y, Qian J, Mao C, et al
    Safety and efficacy of sintilimab combined with oxaliplatin/capecitabine as first-line treatment in patients with locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma in a phase Ib clinical trial.
    BMC Cancer. 2020;20:760.
    >> Share

  61. SHADMANI FK, Farzadfar F, Yoosefi M, Mansori K, et al
    Premature mortality of gastrointestinal cancer in Iran: trends and projections 2001-2030.
    BMC Cancer. 2020;20:752.
    >> Share

    July 2020
  62. MATSUMOTO T, Yamamoto Y, Kuriona Y, Okazaki U, et al
    Efficacy and safety of nivolumab for advanced gastric cancer patients with poor performance statuses.
    BMC Cancer. 2020;20:684.
    >> Share

  63. YANG C, Shi Y, Xie S, Chen J, et al
    Short-term outcomes of robotic- versus laparoscopic-assisted Total Gastrectomy for advanced gastric Cancer: a propensity score matching study.
    BMC Cancer. 2020;20:669.
    >> Share

  64. ZHOU K, Wang A, Ao S, Chen J, et al
    The prognosis of hepatoid adenocarcinoma of the stomach: a propensity score-based analysis.
    BMC Cancer. 2020;20:671.
    >> Share

  65. LIN JL, Lin JX, Zheng CH, Li P, et al
    Relationship between aspirin use of esophageal, gastric and colorectal cancer patient survival: a meta-analysis.
    BMC Cancer. 2020;20:638.
    >> Share

  66. EBRAHIMI GHAHNAVIEH L, Tabatabaeian H, Ebrahimi Ghahnavieh Z, Honardoost MA, et al
    Fluctuating expression of miR-584 in primary and high-grade gastric cancer.
    BMC Cancer. 2020;20:621.
    >> Share

    June 2020
  67. PENG Z, Guan Q, Luo J, Deng W, et al
    Sophoridine exerts tumor-suppressive activities via promoting ESRRG-mediated beta-catenin degradation in gastric cancer.
    BMC Cancer. 2020;20:582.
    >> Share

  68. REHKAEMPER J, Korenkov M, Quaas A, Rueschoff J, et al
    Amplification of KRAS and its heterogeneity in non-Asian gastric adenocarcinomas.
    BMC Cancer. 2020;20:587.
    >> Share

  69. HIRATA K, Hamamoto Y, Ando M, Imamura CK, et al
    Weekly paclitaxel plus ramucirumab versus weekly nab-paclitaxel plus ramucirumab for unresectable advanced or recurrent gastric cancer with peritoneal dissemination refractory to first-line therapy-the P-SELECT trial (WJOG10617G)-a randomised phase II
    BMC Cancer. 2020;20:548.
    >> Share

  70. RICHARDS HS, Blazeby JM, Portal A, Harding R, et al
    A real-time electronic symptom monitoring system for patients after discharge following surgery: a pilot study in cancer-related surgery.
    BMC Cancer. 2020;20:543.
    >> Share

  71. SUN QH, Yin ZX, Li Z, Tian SB, et al
    miR-874 inhibits gastric cancer cell proliferation by targeting SPAG9.
    BMC Cancer. 2020;20:522.
    >> Share

  72. TOYOKAWA T, Muguruma K, Yoshii M, Tamura T, et al
    Clinical significance of prognostic inflammation-based and/or nutritional markers in patients with stage III gastric cancer.
    BMC Cancer. 2020;20:517.
    >> Share

  73. GU E, Song W, Liu A, Wang H, et al
    SCDb: an integrated database of stomach cancer.
    BMC Cancer. 2020;20:490.
    >> Share

  74. TAVAKOLI A, Monavari SH, Solaymani Mohammadi F, Kiani SJ, et al
    Association between Epstein-Barr virus infection and gastric cancer: a systematic review and meta-analysis.
    BMC Cancer. 2020;20:493.
    >> Share

  75. TINTELNOT J, Goekkurt E, Binder M, Thuss-Patience P, et al
    Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INTEGA trial (AIO STO 0217).
    BMC Cancer. 2020;20:503.
    >> Share

    May 2020
  76. SUN KY, Hu HT, Chen SL, Ye JN, et al
    CT-based radiomics scores predict response to neoadjuvant chemotherapy and survival in patients with gastric cancer.
    BMC Cancer. 2020;20:468.
    >> Share

  77. KPOGHOMOU MA, Wang J, Wang T, Jin G, et al
    Association of Helicobacter pylori babA2 gene and gastric cancer risk: a meta-analysis.
    BMC Cancer. 2020;20:465.
    >> Share

  78. LI WH, Zhang JY, Liu WH, Chen XX, et al
    Role of the initial degree of anaemia and treatment model in the prognosis of gastric cancer patients treated by chemotherapy: a retrospective analysis.
    BMC Cancer. 2020;20:414.
    >> Share

  79. O'NEILL L, Guinan E, Doyle S, Connolly D, et al
    Rehabilitation strategies following oesophagogastric and Hepatopancreaticobiliary cancer (ReStOre II): a protocol for a randomized controlled trial.
    BMC Cancer. 2020;20:415.
    >> Share

  80. TANG S, Lin L, Cheng J, Zhao J, et al
    The prognostic value of preoperative fibrinogen-to-prealbumin ratio and a novel FFC score in patients with resectable gastric cancer.
    BMC Cancer. 2020;20:382.
    >> Share

    April 2020
  81. NAKAMURA N, Kinami S, Tomita Y, Miyata T, et al
    The neutrophil/lymphocyte ratio as a predictor of successful conversion surgery for stage IV gastric cancer: a retrospective study.
    BMC Cancer. 2020;20:363.
    >> Share

  82. THERKILDSEN C, Rasmussen M, Smith-Hansen L, Kallemose T, et al
    Broadening risk profile in familial colorectal cancer type X; increased risk for five cancer types in the national Danish cohort.
    BMC Cancer. 2020;20:345.
    >> Share

  83. KAWAI S, Fukuda N, Yamamoto S, Mitani S, et al
    Retrospective observational study of salvage line ramucirumab monotherapy for patients with advanced gastric cancer.
    BMC Cancer. 2020;20:338.
    >> Share

  84. YOON SJ, Park J, Shin Y, Choi Y, et al
    Deconvolution of diffuse gastric cancer and the suppression of CD34 on the BALB/c nude mice model.
    BMC Cancer. 2020;20:314.
    >> Share

    March 2020
  85. BEEHARRY MK, Ni ZT, Yang ZY, Zheng YN, et al
    Study protocol of a multicenter phase III randomized controlled trial investigating the efficiency of the combination of neoadjuvant chemotherapy (NAC) and neoadjuvant laparoscopic intraperitoneal hyperthermic chemotherapy (NLHIPEC) followed by R0 gas
    BMC Cancer. 2020;20:224.
    >> Share

  86. WANG M, Li Z, Peng Y, Fang J, et al
    Identification of immune cells and mRNA associated with prognosis of gastric cancer.
    BMC Cancer. 2020;20:206.
    >> Share

  87. KONO Y, Saito H, Miyauchi W, Shimizu S, et al
    Increased PD-1-positive macrophages in the tissue of gastric cancer are closely associated with poor prognosis in gastric cancer patients.
    BMC Cancer. 2020;20:175.
    >> Share

  88. CHOI JH, Choi YW, Kang SY, Jeong GS, et al
    Combination versus single-agent as palliative chemotherapy for gastric cancer.
    BMC Cancer. 2020;20:167.
    >> Share

    February 2020
  89. ZHENG G, Liu J, Guo Y, Wang F, et al
    Necessity of prophylactic splenic hilum lymph node clearance for middle and upper third gastric cancer: a network meta-analysis.
    BMC Cancer. 2020;20:149.
    >> Share

    January 2020
  90. HU X, Zhao F, Yu H, Luo Y, et al
    GC-PROM: validation of a patient-reported outcomes measure for Chinese patients with gastric cancer.
    BMC Cancer. 2020;20:41.
    >> Share

  91. MOORE A, Hikri E, Goshen-Lago T, Barkan T, et al
    Young-onset gastric cancer and Epstein-Barr Virus (EBV) - a major player in the pathogenesis?
    BMC Cancer. 2020;20:34.
    >> Share

  92. LIN JX, Lin JP, Xie JW, Wang JB, et al
    Complete blood count-based inflammatory score (CBCS) is a novel prognostic marker for gastric cancer patients after curative resection.
    BMC Cancer. 2020;20:11.
    >> Share

  93. WANG CY, Yang J, Zi H, Zheng ZL, et al
    Nomogram for predicting the survival of gastric adenocarcinoma patients who receive surgery and chemotherapy.
    BMC Cancer. 2020;20:10.
    >> Share

    December 2019
  94. BEEHARRY MK, Zhu ZL, Liu WT, Yao XX, et al
    Correction to: Prophylactic HIPEC with radical D2 gastrectomy improves survival and peritoneal recurrence rates for locally advanced gastric cancer: personal experience from a randomized case control study.
    BMC Cancer. 2019;19:1256.
    >> Share

  95. SHIN K, Park SJ, Lee J, Park CH, et al
    Efficacy of capecitabine and oxaliplatin versus S-1 as adjuvant chemotherapy in gastric cancer after D2 lymph node dissection according to lymph node ratio and N stage.
    BMC Cancer. 2019;19:1232.
    >> Share

  96. KOSUGA T, Konishi T, Kubota T, Shoda K, et al
    Clinical significance of neutrophil-to-lymphocyte ratio as a predictor of lymph node metastasis in gastric cancer.
    BMC Cancer. 2019;19:1187.
    >> Share

    November 2019
  97. ZHENG HL, Lu J, Xie JW, Wang JB, et al
    Exploring the value of new preoperative inflammation prognostic score: white blood cell to hemoglobin for gastric adenocarcinoma patients.
    BMC Cancer. 2019;19:1127.
    >> Share

  98. GUO X, Zhao F, Ma X, Shen G, et al
    A comparison between triplet and doublet chemotherapy in improving the survival of patients with advanced gastric cancer: a systematic review and meta-analysis.
    BMC Cancer. 2019;19:1125.
    >> Share

  99. WANG X, Zhao J, Fairweather M, Yang T, et al
    Optimal treatment for elderly patients with resectable proximal gastric carcinoma: a real world study based on National Cancer Database.
    BMC Cancer. 2019;19:1079.
    >> Share

  100. LIN JX, Wang ZK, Wang W, Desiderio J, et al
    Risk factors of lymph node metastasis or lymphovascular invasion for early gastric cancer: a practical and effective predictive model based on international multicenter data.
    BMC Cancer. 2019;19:1048.
    >> Share

    October 2019
  101. LIU P, McMenamin UC, Spence AD, Johnston BT, et al
    Furosemide use and survival in patients with esophageal or gastric cancer: a population-based cohort study.
    BMC Cancer. 2019;19:1017.
    >> Share

  102. BU X, Zhang A, Chen Z, Zhang X, et al
    Migration of gastric cancer is suppressed by recombinant Newcastle disease virus (rL-RVG) via regulating alpha7-nicotinic acetylcholine receptors/ERK- EMT.
    BMC Cancer. 2019;19:976.
    >> Share

  103. MASUDA K, Shoji H, Nagashima K, Yamamoto S, et al
    Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab.
    BMC Cancer. 2019;19:974.
    >> Share

  104. TANIOKA H, Nagasaka T, Uno F, Inoue M, et al
    The relationship between peripheral neuropathy and efficacy in second-line chemotherapy for unresectable advanced gastric cancer: a prospective observational multicenter study protocol (IVY).
    BMC Cancer. 2019;19:941.
    >> Share

    September 2019
  105. YOU X, Zhou Q, Song J, Gan L, et al
    Preoperative albumin-to-fibrinogen ratio predicts severe postoperative complications in elderly gastric cancer subjects after radical laparoscopic gastrectomy.
    BMC Cancer. 2019;19:931.
    >> Share

  106. BEEHARRY MK, Zhu ZL, Liu WT, Yao XX, et al
    Prophylactic HIPEC with radical D2 gastrectomy improves survival and peritoneal recurrence rates for locally advanced gastric cancer: personal experience from a randomized case control study.
    BMC Cancer. 2019;19:932.
    >> Share

  107. MESIC A, Rogar M, Hudler P, Bilalovic N, et al
    Characterization and risk association of polymorphisms in Aurora kinases A, B and C with genetic susceptibility to gastric cancer development.
    BMC Cancer. 2019;19:919.
    >> Share

  108. LU J, Xu Y, Wu Y, Huang XY, et al
    Tumor-infiltrating CD8+ T cells combined with tumor-associated CD68+ macrophages predict postoperative prognosis and adjuvant chemotherapy benefit in resected gastric cancer.
    BMC Cancer. 2019;19:920.
    >> Share

  109. DING P, Gao Z, Zheng C, Chen J, et al
    Risk evaluation of splenic hilar or splenic artery lymph node metastasis and survival analysis for patients with proximal gastric cancer after curative gastrectomy: a retrospective study.
    BMC Cancer. 2019;19:905.
    >> Share

  110. YEO ST, Bray N, Haboubi H, Hoare Z, et al
    Endoscopic ultrasound staging in patients with gastro-oesophageal cancers: a systematic review of economic evidence.
    BMC Cancer. 2019;19:900.
    >> Share

  111. LIN JL, Lin JX, Li P, Xie JW, et al
    Dynamic prediction of long-term survival in patients with primary gastric diffuse large B-cell lymphoma: a SEER population-based study.
    BMC Cancer. 2019;19:873.
    >> Share

  112. KIM H, Son SM, Woo CG, Lee OJ, et al
    Discordance in HER2 status between primary gastric adenocarcinoma tumors and cells from the corresponding malignant effusions.
    BMC Cancer. 2019;19:834.
    >> Share

    August 2019
  113. MA T, Wu ZJ, Xu H, Wu CH, et al
    Nomograms for predicting survival in patients with metastatic gastric adenocarcinoma who undergo palliative gastrectomy.
    BMC Cancer. 2019;19:852.
    >> Share

  114. CHENG Y, Xiao Y, Zhou R, Liao Y, et al
    Prognostic significance of helicobacter pylori-infection in gastric diffuse large B-cell lymphoma.
    BMC Cancer. 2019;19:842.
    >> Share

  115. YUAN P, Wu Z, Li Z, Bu Z, et al
    Impact of postoperative major complications on long-term survival after radical resection of gastric cancer.
    BMC Cancer. 2019;19:833.
    >> Share

  116. TANG X, He Q, Qu H, Sun G, et al
    Post-therapy pathologic tumor volume predicts survival in gastric cancer patients who underwent neoadjuvant chemotherapy and gastrectomy.
    BMC Cancer. 2019;19:797.
    >> Share

  117. PAK KH, Park KC, Cheong JH
    VEGF-C induced by TGF- beta1 signaling in gastric cancer enhances tumor-induced lymphangiogenesis.
    BMC Cancer. 2019;19:799.
    >> Share

  118. LIU G, Hu Y, Cheng X, Wang Y, et al
    Volumetric parameters on (18)F-FDG PET/CT predict the survival of patients with gastric cancer associated with their expression status of c-MET.
    BMC Cancer. 2019;19:790.
    >> Share

  119. LIU J, Liu Z, Zhang X, Gong T, et al
    Correction to: Bioinformatic exploration of OLFML2B overexpression in gastric cancer base on multiple analyzing tools.
    BMC Cancer. 2019;19:759.
    >> Share

    July 2019
  120. MEI JW, Yang ZY, Xiang HG, Bao R, et al
    MicroRNA-1275 inhibits cell migration and invasion in gastric cancer by regulating vimentin and E-cadherin via JAZF1.
    BMC Cancer. 2019;19:740.
    >> Share

  121. JO MJ, Jeong S, Yun HK, Kim DY, et al
    Genipin induces mitochondrial dysfunction and apoptosis via downregulation of Stat3/mcl-1 pathway in gastric cancer.
    BMC Cancer. 2019;19:739.
    >> Share

  122. HIRAHARA T, Arigami T, Yanagita S, Matsushita D, et al
    Combined neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts chemotherapy response and prognosis in patients with advanced gastric cancer.
    BMC Cancer. 2019;19:672.
    >> Share

  123. ARAI H, Iwasa S, Boku N, Kawahira M, et al
    Fluoropyrimidine with or without platinum as first-line chemotherapy in patients with advanced gastric cancer and severe peritoneal metastasis: a multicenter retrospective study.
    BMC Cancer. 2019;19:652.
    >> Share

  124. XU J, Zhu R, Fan L, Ge S, et al
    Prognostic value of DNA aneuploidy in gastric cancer: a meta-analysis of 3449 cases.
    BMC Cancer. 2019;19:650.
    >> Share

    June 2019
  125. QI Y, Lv J, Liu S, Sun L, et al
    TSPAN9 and EMILIN1 synergistically inhibit the migration and invasion of gastric cancer cells by increasing TSPAN9 expression.
    BMC Cancer. 2019;19:630.
    >> Share

  126. LIU X, Jin J, Cai H, Huang H, et al
    Study protocol of a randomized phase III trial of comparing preoperative chemoradiation with preoperative chemotherapy in patients with locally advanced gastric cancer or esophagogastric junction adenocarcinoma: PREACT.
    BMC Cancer. 2019;19:606.
    >> Share

  127. DOMINGUEZ RL, Cherry CB, Estevez-Ordonez D, Mera R, et al
    Geospatial analyses identify regional hot spots of diffuse gastric cancer in rural Central America.
    BMC Cancer. 2019;19:545.
    >> Share

    May 2019
  128. DONG C, Sun J, Ma S, Zhang G, et al
    K-ras-ERK1/2 down-regulates H2A.X(Y142ph) through WSTF to promote the progress of gastric cancer.
    BMC Cancer. 2019;19:530.
    >> Share

  129. LI Y, Yan X, Shi J, He Y, et al
    Aberrantly expressed miR-188-5p promotes gastric cancer metastasis by activating Wnt/beta-catenin signaling.
    BMC Cancer. 2019;19:505.
    >> Share

  130. WAGNER AD, Grabsch HI, Mauer M, Marreaud S, et al
    EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction
    BMC Cancer. 2019;19:494.
    >> Share

  131. XIA X, Xu J, Zhu C, Cao H, et al
    Objective evaluation of clinical outcomes of laparoscopy-assisted pylorus-preserving gastrectomy for middle-third early gastric cancer.
    BMC Cancer. 2019;19:481.
    >> Share

  132. KIM YJ, Chung WC, Jun KH, Chin HM, et al
    Genetic polymorphisms of vascular endothelial growth factor (VEGF) associated with gastric cancer recurrence after curative resection with adjuvant chemotherapy.
    BMC Cancer. 2019;19:483.
    >> Share

  133. WANG F, He MM, Wang ZX, Li S, et al
    Phase I study of high-dose ascorbic acid with mFOLFOX6 or FOLFIRI in patients with metastatic colorectal cancer or gastric cancer.
    BMC Cancer. 2019;19:460.
    >> Share

  134. LI Q, Xu X, Su D, Zhou T, et al
    Long-term survival of an elderly patient with advanced gastric cancer after combination therapy: a case report and literature review.
    BMC Cancer. 2019;19:459.
    >> Share

  135. MARTINEZ-CAMPOS C, Torres-Poveda K, Camorlinga-Ponce M, Flores-Luna L, et al
    Polymorphisms in IL-10 and TGF-beta gene promoter are associated with lower risk to gastric cancer in a Mexican population.
    BMC Cancer. 2019;19:453.
    >> Share

  136. KOEMANS WJ, van der Kaaij RT, Boot H, Buffart T, et al
    Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II).
    BMC Cancer. 2019;19:420.
    >> Share

    April 2019
  137. LI C, Wang X, Wang X, Han C, et al
    A multicenter phase III study comparing Simultaneous Integrated Boost (SIB) radiotherapy concurrent and consolidated with S-1 versus SIB alone in elderly patients with esophageal and esophagogastric cancer - the 3JECROG P-01 study protocol.
    BMC Cancer. 2019;19:397.
    >> Share

  138. LI WY, Han Y, Xu HM, Wang ZN, et al
    Smoking status and subsequent gastric cancer risk in men compared with women: a meta-analysis of prospective observational studies.
    BMC Cancer. 2019;19:377.
    >> Share

  139. LV Y, Han X, Xu XF, Ji Y, et al
    Risk factors affecting prognosis in metachronous liver metastases from WHO classification G1 and G2 gastroenteropancreatic neuroendocrine tumors after initial R0 surgical resection.
    BMC Cancer. 2019;19:335.
    >> Share

  140. LI L, Kang D, Huang Z, Zhan Z, et al
    Multimodal multiphoton imaging for label-free monitoring of early gastric cancer.
    BMC Cancer. 2019;19:295.
    >> Share

    March 2019
  141. DI BARTOLOMEO M, Niger M, Morano F, Corallo S, et al
    Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: the ARMANI phase III trial.
    BMC Cancer. 2019;19:283.
    >> Share

  142. SUI H, Lou A, Li Z, Yang J, et al
    Lidocaine inhibits growth, migration and invasion of gastric carcinoma cells by up-regulation of miR-145.
    BMC Cancer. 2019;19:233.
    >> Share

  143. LIU J, Liu Z, Zhang X, Gong T, et al
    Bioinformatic exploration of OLFML2B overexpression in gastric cancer base on multiple analyzing tools.
    BMC Cancer. 2019;19:227.
    >> Share

  144. LU J, Dai Y, Xie JW, Wang JB, et al
    Combination of lymphovascular invasion and the AJCC TNM staging system improves prediction of prognosis in N0 stage gastric cancer: results from a high-volume institution.
    BMC Cancer. 2019;19:216.
    >> Share

  145. DONIDA BM, Tomasello G, Ghidini M, Buffoli F, et al
    Epidemiological, clinical and pathological characteristics of gastric neoplasms in the province of Cremona: the experience of the first population-based specialized gastric cancer registry in Italy.
    BMC Cancer. 2019;19:212.
    >> Share

  146. LEE CM, Park JH, In Choi C, Lee HH, et al
    A multi-center prospective randomized controlled trial (phase III) comparing the quality of life between laparoscopy-assisted distal gastrectomy and totally laparoscopic distal gastrectomy for gastric Cancer (study protocol).
    BMC Cancer. 2019;19:206.
    >> Share

    February 2019
  147. LIAN L, Li XL, Xu MD, Li XM, et al
    VEGFR2 promotes tumorigenesis and metastasis in a pro-angiogenic-independent way in gastric cancer.
    BMC Cancer. 2019;19:183.
    >> Share

  148. MAO Y, Yang W, Qi Q, Yu F, et al
    Blood groups A and AB are associated with increased gastric cancer risk: evidence from a large genetic study and systematic review.
    BMC Cancer. 2019;19:164.
    >> Share

  149. KIM TM, Ko YH, Ha SJ, Lee HH, et al
    Impact of in vitro driven expression signatures of CD133 stem cell marker and tumor stroma on clinical outcomes in gastric cancers.
    BMC Cancer. 2019;19:119.
    >> Share

    January 2019
  150. LI Z, Wang Y, Ying X, Shan F, et al
    Different prognostic implication of ypTNM stage and pTNM stage for gastric cancer: a propensity score-matched analysis.
    BMC Cancer. 2019;19:80.
    >> Share

  151. BUSTOS-CARPINTEYRO AR, Oliveira C, Sousa A, Oliveira P, et al
    CDH1 somatic alterations in Mexican patients with diffuse and mixed sporadic gastric cancer.
    BMC Cancer. 2019;19:69.
    >> Share

  152. BRAGA LLBC, Batista MHR, de Azevedo OGR, da Silva Costa KC, et al
    oipA "on" status of Helicobacter pylori is associated with gastric cancer in North-Eastern Brazil.
    BMC Cancer. 2019;19:48.
    >> Share

  153. ZHANG X, Shen B, Cui Y
    Ago HITS-CLIP expands microRNA-mRNA interactions in nucleus and cytoplasm of gastric cancer cells.
    BMC Cancer. 2019;19:29.
    >> Share

  154. LIN MQ, Wang JB, Zheng CH, Li P, et al
    A modified subclassification to evaluate the survival of patients with N3 gastric cancer: an international database study.
    BMC Cancer. 2019;19:21.
    >> Share

  155. SHI Y, Huang X, Chen G, Wang Y, et al
    miR-632 promotes gastric cancer progression by accelerating angiogenesis in a TFF1-dependent manner.
    BMC Cancer. 2019;19:14.
    >> Share

    December 2018
  156. ZHANG J, Qiu W, Liu H, Qian C, et al
    Genomic alterations in gastric cancers discovered via whole-exome sequencing.
    BMC Cancer. 2018;18:1270.
    >> Share

  157. MORI M, Shuto K, Kosugi C, Narushima K, et al
    An increase in the neutrophil-to-lymphocyte ratio during adjuvant chemotherapy indicates a poor prognosis in patients with stage II or III gastric cancer.
    BMC Cancer. 2018;18:1261.
    >> Share

    November 2018
  158. LI Z, Shan F, Ying X, Xue K, et al
    Laparoscopic versus open gastrectomy for elderly local advanced gastric cancer patients: study protocol of a phase II randomized controlled trial.
    BMC Cancer. 2018;18:1118.
    >> Share

  159. BEOM SH, Choi YY, Baek SE, Li SX, et al
    Multidisciplinary treatment for patients with stage IV gastric cancer: the role of conversion surgery following chemotherapy.
    BMC Cancer. 2018;18:1116.
    >> Share

  160. LIU J, Huang C, Peng C, Xu F, et al
    Stromal fibroblast activation protein alpha promotes gastric cancer progression via epithelial-mesenchymal transition through Wnt/ beta-catenin pathway.
    BMC Cancer. 2018;18:1099.
    >> Share

  161. HUANG ZN, Chen QY, Zheng CH, Li P, et al
    Are the indications for postoperative radiotherapy in the NCCN guidelines for patients with gastric adenocarcinoma too broad? A study based on the SEER database.
    BMC Cancer. 2018;18:1064.
    >> Share

    October 2018
  162. MAGALHAES L, Quintana LG, Lopes DCF, Vidal AF, et al
    APC gene is modulated by hsa-miR-135b-5p in both diffuse and intestinal gastric cancer subtypes.
    BMC Cancer. 2018;18:1055.
    >> Share

  163. LIU X, Cai H, Sheng W, Huang H, et al
    microRNAs expression profile related with response to preoperative radiochemotherapy in patients with locally advanced gastric cancer.
    BMC Cancer. 2018;18:1048.
    >> Share

  164. XIE JW, Lu J, Wang JB, Lin JX, et al
    Prognostic factors for survival after curative resection of gastric mixed adenoneuroendocrine carcinoma: a series of 80 patients.
    BMC Cancer. 2018;18:1021.
    >> Share

  165. YAPRAK G, Gemici C, Temizkan S, Ozdemir S, et al
    Osteoporosis development and vertebral fractures after abdominal irradiation in patients with gastric cancer.
    BMC Cancer. 2018;18:972.
    >> Share

  166. HE H, Li H, Su X, Li Z, et al
    Study on safety of laparoscopic total gastrectomy for clinical stage I gastric cancer: the protocol of the CLASS02-01 multicenter randomized controlled clinical trial.
    BMC Cancer. 2018;18:944.
    >> Share

    September 2018
  167. CHEN M, Jiang B, He B, Tang M, et al
    Genetic variations in PRKAA1 predict the risk and progression of gastric Cancer.
    BMC Cancer. 2018;18:923.
    >> Share

  168. SLAGTER AE, Jansen EPM, van Laarhoven HWM, van Sandick JW, et al
    CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in res
    BMC Cancer. 2018;18:877.
    >> Share

  169. FENG F, Liu J, Wang F, Zheng G, et al
    Prognostic value of differentiation status in gastric cancer.
    BMC Cancer. 2018;18:865.
    >> Share

    August 2018
  170. LIU W, Fan Y, Shi Y, Lin Z, et al
    Knockdown of TIPE2 increases the proliferation in lipopolysaccharide-stimulated gastric cancer cells.
    BMC Cancer. 2018;18:857.
    >> Share

  171. HUSSEIN UK, Park HS, Bae JS, Kim KM, et al
    Expression of oxidized protein tyrosine phosphatase and gammaH2AX predicts poor survival of gastric carcinoma patients.
    BMC Cancer. 2018;18:836.
    >> Share

  172. LI N, Wang X, Tang Y, Zhao D, et al
    A prospective phase I study of hypo-fractionated neoadjuvant radiotherapy for locally advanced gastric cancer.
    BMC Cancer. 2018;18:803.
    >> Share

  173. HU D, Peng F, Lin X, Chen G, et al
    Prediction of three lipid derivatives for postoperative gastric cancer mortality: the Fujian prospective investigation of cancer (FIESTA) study.
    BMC Cancer. 2018;18:785.
    >> Share

    July 2018
  174. HWANG H, Lee KM, Son KL, Jung D, et al
    Incidence and risk factors of subsyndromal delirium after curative resection of gastric cancer.
    BMC Cancer. 2018;18:765.
    >> Share

  175. WANG Z, Li M, Xu Z, Jiang Y, et al
    Improvements to the gastric cancer tumor-node-metastasis staging system based on computer-aided unsupervised clustering.
    BMC Cancer. 2018;18:706.
    >> Share

    June 2018
  176. LIU X, Zhang D, Lin E, Chen Y, et al
    Preoperative controlling nutritional status (CONUT) score as a predictor of long-term outcome after curative resection followed by adjuvant chemotherapy in stage II-III gastric Cancer.
    BMC Cancer. 2018;18:699.
    >> Share

  177. WANG Y, Cheng X, Cui YH, Hou J, et al
    Efficacy after preoperative capecitabine and oxaliplatin (XELOX) versus docetaxel, oxaliplatin and S1 (DOS) in patients with locally advanced gastric adenocarcinoma: a propensity score matching analysis.
    BMC Cancer. 2018;18:702.
    >> Share

  178. WANG Y, Chen Y, Li X, Hu W, et al
    Loss of expression and prognosis value of alpha-internexin in gastroenteropancreatic neuroendocrine neoplasm.
    BMC Cancer. 2018;18:691.
    >> Share

  179. ZHAO G, Jiang T, Liu Y, Huai G, et al
    Droplet digital PCR-based circulating microRNA detection serve as a promising diagnostic method for gastric cancer.
    BMC Cancer. 2018;18:676.
    >> Share

  180. LIU X, Ma M, Huang H, Wang Y, et al
    Effect of perioperative blood transfusion on prognosis of patients with gastric cancer: a retrospective analysis of a single center database.
    BMC Cancer. 2018;18:649.
    >> Share

  181. KUBO N, Yoshizawa J, Hanaoka T
    Solitary metastasis to a superior mediastinal lymph node after distal gastrectomy for gastric cancer: a case report.
    BMC Cancer. 2018;18:627.
    >> Share

    May 2018
  182. LIU Z, Zheng G, Liu J, Liu S, et al
    Clinicopathological features, surgical strategy and prognosis of duodenal gastrointestinal stromal tumors: a series of 300 patients.
    BMC Cancer. 2018;18:563.
    >> Share

  183. WANG G, Zhao J, Song Y, Zhang W, et al
    Phase II study of adjuvant chemotherapy with S1 plus oxaliplatin for Chinese patients with gastric cancer.
    BMC Cancer. 2018;18:547.
    >> Share

  184. SCHNEIDER PM, Eshmuminov D, Rordorf T, Vetter D, et al
    (18)FDG-PET-CT identifies histopathological non-responders after neoadjuvant chemotherapy in locally advanced gastric and cardia cancer: cohort study.
    BMC Cancer. 2018;18:548.
    >> Share

  185. HSIEH YY, Tung SY, Pan HY, Yen CW, et al
    Upregulation of bone morphogenetic protein 1 is associated with poor prognosis of late-stage gastric Cancer patients.
    BMC Cancer. 2018;18:508.
    >> Share

  186. HUANG Z, Liu Y, Yang C, Li X, et al
    Combined neutrophil/platelet/lymphocyte/differentiation score predicts chemosensitivity in advanced gastric cancer.
    BMC Cancer. 2018;18:515.
    >> Share

  187. HONG SA, Yoo SH, Lee HH, Sun S, et al
    Prognostic value of Dickkopf-1 and ss-catenin expression in advanced gastric cancer.
    BMC Cancer. 2018;18:506.
    >> Share

  188. KHAN S, Zhu LP, Zhang Y, Chen X, et al
    Laterally spreading tumour of the distal stomach: a case report.
    BMC Cancer. 2018;18:502.
    >> Share

    April 2018
  189. WANG T, Lu ZY, Tu XF, Zhang SH, et al
    Computerized tomography findings in calcified signet-ring gastric cancer receiving chemotherapy: a case report.
    BMC Cancer. 2018;18:474.
    >> Share

  190. LINK H, Angele M, Schuller M, Ganschow P, et al
    Extra-capsular growth of lymph node metastasis correlates with poor prognosis and high SOX9 expression in gastric cancer.
    BMC Cancer. 2018;18:483.
    >> Share

  191. ZHANG C, Li Z, Xu L, Che X, et al
    CXCL9/10/11, a regulator of PD-L1 expression in gastric cancer.
    BMC Cancer. 2018;18:462.
    >> Share

  192. ITO S, Ohashi Y, Sasako M
    Survival after recurrence in patients with gastric cancer who receive S-1 adjuvant chemotherapy: exploratory analysis of the ACTS-GC trial.
    BMC Cancer. 2018;18:449.
    >> Share

  193. BRENKMAN HJF, Gertsen EC, Vegt E, van Hillegersberg R, et al
    Evaluation of PET and laparoscopy in STagIng advanced gastric cancer: a multicenter prospective study (PLASTIC-study).
    BMC Cancer. 2018;18:450.
    >> Share

  194. SUN XJ, Shi JF, Guo LW, Huang HY, et al
    Medical expenses of urban Chinese patients with stomach cancer during 2002-2011: a hospital-based multicenter retrospective study.
    BMC Cancer. 2018;18:435.
    >> Share

  195. LIU HN, Wu H, Tseng YJ, Chen YJ, et al
    Serum microRNA signatures and metabolomics have high diagnostic value in gastric cancer.
    BMC Cancer. 2018;18:415.
    >> Share

  196. GIRARDI DM, de Lima MA, Pereira GCB, Negrao MV, et al
    Chemoradiotherapy versus chemotherapy as adjuvant treatment for localized gastric cancer: a propensity score-matched analysis.
    BMC Cancer. 2018;18:378.
    >> Share

    March 2018
  197. SUNDAR R, Rha SY, Yamaue H, Katsuda M, et al
    A phase I/Ib study of OTSGC-A24 combined peptide vaccine in advanced gastric cancer.
    BMC Cancer. 2018;18:332.
    >> Share

  198. ZHANG N, Chai D, Du H, Li K, et al
    Expression of Reg IV and SOX9 and their correlation in human gastric cancer.
    BMC Cancer. 2018;18:344.
    >> Share

  199. HAMASHIMA C, Sano H
    Association between age factors and strategies for promoting participation in gastric and colorectal cancer screenings.
    BMC Cancer. 2018;18:345.
    >> Share

  200. MULLER V, Clemens M, Jassem J, Al-Sakaff N, et al
    Long-term trastuzumab (Herceptin(R)) treatment in a continuation study of patients with HER2-positive breast cancer or HER2-positive gastric cancer.
    BMC Cancer. 2018;18:295.
    >> Share

  201. HIRAHARA N, Tajima Y, Fujii Y, Kaji S, et al
    Prognostic nutritional index as a predictor of survival in resectable gastric cancer patients with normal preoperative serum carcinoembryonic antigen levels: a propensity score matching analysis.
    BMC Cancer. 2018;18:285.
    >> Share

    February 2018
  202. LEE YH, Lee JW, Jang HS
    Correction to: Palliative external beam radiotherapy for the treatment of tumor bleeding in inoperable advanced gastric cancer.
    BMC Cancer. 2018;18:232.
    >> Share

  203. JIAO XD, Ding C, Zang YS, Yu G, et al
    Rapid symptomatic relief of HER2-positive gastric cancer leptomeningeal carcinomatosis with lapatinib, trastuzumab and capecitabine: a case report.
    BMC Cancer. 2018;18:206.
    >> Share

  204. NAMIKAWA T, Maeda H, Kitagawa H, Oba K, et al
    Treatment using oxaliplatin and S-1 adjuvant chemotherapy for pathological stage III gastric cancer: a multicenter phase II study (TOSA trial) protocol.
    BMC Cancer. 2018;18:186.
    >> Share

  205. AHN MJ, Lee K, Lee KH, Kim JW, et al
    Combination of anti-PD-1 therapy and stereotactic radiosurgery for a gastric cancer patient with brain metastasis: a case report.
    BMC Cancer. 2018;18:173.
    >> Share

  206. FENG F, Zheng G, Guo X, Liu Z, et al
    Impact of body mass index on surgical outcomes of gastric cancer.
    BMC Cancer. 2018;18:151.
    >> Share

  207. KIM SH, Yoo HS, Joo MK, Kim T, et al
    Arsenic trioxide attenuates STAT-3 activity and epithelial-mesenchymal transition through induction of SHP-1 in gastric cancer cells.
    BMC Cancer. 2018;18:150.
    >> Share

  208. MARIETTE C, Renaud F, Piessen G, Gele P, et al
    The FREGAT biobank: a clinico-biological database dedicated to esophageal and gastric cancers.
    BMC Cancer. 2018;18:139.
    >> Share

  209. BRAGA-NETO MB, Carneiro JG, de Castro Barbosa AM, Silva IS, et al
    Clinical characteristics of distal gastric cancer in young adults from Northeastern Brazil.
    BMC Cancer. 2018;18:131.
    >> Share

    January 2018
  210. MIAO ZF, Liu XY, Wang ZN, Zhao TT, et al
    Effect of neoadjuvant chemotherapy in patients with gastric cancer: a PRISMA-compliant systematic review and meta-analysis.
    BMC Cancer. 2018;18:118.
    >> Share

  211. MATSUMOTO H, Kawazoe A, Shimada K, Fukuoka S, et al
    A retrospective study of the safety and efficacy of paclitaxel plus ramucirumab in patients with advanced or recurrent gastric cancer with ascites.
    BMC Cancer. 2018;18:120.
    >> Share

  212. NISHIBEPPU K, Komatsu S, Ichikawa D, Imamura T, et al
    Venous invasion as a risk factor for recurrence after gastrectomy followed by chemotherapy for stage III gastric cancer.
    BMC Cancer. 2018;18:108.
    >> Share

  213. CAO QH, Liu F, Li CZ, Liu N, et al
    Testes-specific protease 50 (TSP50) promotes invasion and metastasis by inducing EMT in gastric cancer.
    BMC Cancer. 2018;18:94.
    >> Share

  214. MACALINDONG SS, Kim KH, Nam BH, Ryu KW, et al
    Effect of total number of harvested lymph nodes on survival outcomes after curative resection for gastric adenocarcinoma: findings from an eastern high-volume gastric cancer center.
    BMC Cancer. 2018;18:73.
    >> Share

  215. LI Z, Li Z, Zhang L, Liu Q, et al
    Staging laparoscopy for locally advanced gastric cancer in Chinese patients: a multicenter prospective registry study.
    BMC Cancer. 2018;18:63.
    >> Share

  216. SAEKI H, Emi Y, Oki E, Tokunaga S, et al
    Study protocol of a phase II clinical trial (KSCC1501A) examining oxaliplatin + S-1 for treatment of HER2-negative advanced/recurrent gastric cancer previously untreated with chemotherapy.
    BMC Cancer. 2018;18:57.
    >> Share

  217. ZENG B, Shi W, Tan G
    MiR-199a/b-3p inhibits gastric cancer cell proliferation via down-regulating PAK4/MEK/ERK signaling pathway.
    BMC Cancer. 2018;18:34.
    >> Share

    December 2017
  218. HUANG J, He Y, Mcleod HL, Xie Y, et al
    miR-302b inhibits tumorigenesis by targeting EphA2 via Wnt/ beta-catenin/EMT signaling cascade in gastric cancer.
    BMC Cancer. 2017;17:886.
    >> Share

  219. LU Y, Xu Q, Zuo Y, Liu L, et al
    Isoprenaline/beta2-AR activates Plexin-A1/VEGFR2 signals via VEGF secretion in gastric cancer cells to promote tumor angiogenesis.
    BMC Cancer. 2017;17:875.
    >> Share

  220. KELLER S, Kneissl J, Grabher-Meier V, Heindl S, et al
    Evaluation of epidermal growth factor receptor signaling effects in gastric cancer cell lines by detailed motility-focused phenotypic characterization linked with molecular analysis.
    BMC Cancer. 2017;17:845.
    >> Share

  221. CAO GD, Chen K, Chen B, Xiong MM, et al
    Positive prognostic value of HER2-HER3 co-expression and p-mTOR in gastric cancer patients.
    BMC Cancer. 2017;17:841.
    >> Share

  222. KAWAMOTO Y, Komatsu Y, Yuki S, Sawada K, et al
    Study protocol of HGCSG1404 SNOW study: a phase I/II trial of combined chemotherapy of S-1, nab-paclitaxel and oxaliplatin administered biweekly to patients with advanced gastric cancer.
    BMC Cancer. 2017;17:837.
    >> Share

    November 2017
  223. GHOSH S, Bankura B, Ghosh S, Saha ML, et al
    Polymorphisms in ADH1B and ALDH2 genes associated with the increased risk of gastric cancer in West Bengal, India.
    BMC Cancer. 2017;17:782.
    >> Share

  224. RYU BK, Lee MG, Kim NH, Lee KY, et al
    Bidirectional alteration of Cav-1 expression is associated with mitogenic conversion of its function in gastric tumor progression.
    BMC Cancer. 2017;17:766.
    >> Share

  225. HAMASHIMA C, Narisawa R, Ogoshi K, Kato T, et al
    Optimal interval of endoscopic screening based on stage distributions of detected gastric cancers.
    BMC Cancer. 2017;17:740.
    >> Share

  226. FENG F, Tian Y, Xu G, Liu Z, et al
    Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer.
    BMC Cancer. 2017;17:737.
    >> Share

    October 2017
  227. GUAN P, Chen Z, Zhang L, Pan L, et al
    Dilemmas in a pregnant woman with myelofibrosis secondary to signet ring adenocarcinoma: a case report.
    BMC Cancer. 2017;17:679.
    >> Share

  228. LEE HH, Lee SH, Song KY, Na SJ, et al
    Evaluation of Slug expression is useful for predicting lymph node metastasis and survival in patients with gastric cancer.
    BMC Cancer. 2017;17:670.
    >> Share

  229. SANCHEZ-ZAUCO N, Torres J, Gomez A, Camorlinga-Ponce M, et al
    Correction to: Circulating blood levels of IL-6, IFN-gamma, and IL-10 as potential diagnostic biomarkers in gastric cancer: a controlled study.
    BMC Cancer. 2017;17:669.
    >> Share

  230. LIU S, Zhang Y, Chen L, Guan W, et al
    Whole-lesion apparent diffusion coefficient histogram analysis: significance in T and N staging of gastric cancers.
    BMC Cancer. 2017;17:665.
    >> Share

    September 2017
  231. REYNOLDS KL, Bedard PL, Lee SH, Lin CC, et al
    A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer.
    BMC Cancer. 2017;17:646.
    >> Share

  232. YE J, Huang J, Xu J, Huang Q, et al
    ERp29 controls invasion and metastasis of gastric carcinoma by inhibition of epithelial-mesenchymal transition via PI3K/Aktsignaling pathway.
    BMC Cancer. 2017;17:626.
    >> Share

    August 2017
  233. PARK SM, Lee J, Kim YA, Chang YJ, et al
    Factors related with colorectal and stomach cancer screening practice among disease-free lung cancer survivors in Korea.
    BMC Cancer. 2017;17:600.
    >> Share

  234. JI X, Bu ZD, Li ZY, Wu AW, et al
    Prognostic significance of the total number of harvested lymph nodes for lymph node-negative gastric cancer patients.
    BMC Cancer. 2017;17:558.
    >> Share

  235. LEE YH, Lee JW, Jang HS
    Palliative external beam radiotherapy for the treatment of tumor bleeding in inoperable advanced gastric cancer.
    BMC Cancer. 2017;17:541.
    >> Share

    July 2017
  236. HAAG GM, Stocker G, Quidde J, Jaeger D, et al
    Randomized controlled trial of S-1 maintenance therapy in metastatic esophagogastric cancer - the multinational MATEO study.
    BMC Cancer. 2017;17:509.
    >> Share

    June 2017
  237. YOSHIZAWA J, Kubo N, Ishizone S, Karasawa F, et al
    Curative resection by splenectomy for solitary splenic metastasis from early gastric cancer: a case report and literature review.
    BMC Cancer. 2017;17:436.
    >> Share

    May 2017
  238. SANCHEZ-ZAUCO N, Torres J, Gomez A, Camorlinga-Ponce M, et al
    Circulating blood levels of IL-6, IFN-gamma, and IL-10 as potential diagnostic biomarkers in gastric cancer: a controlled study.
    BMC Cancer. 2017;17:384.
    >> Share

  239. CHANG YW, Oh CH, Kim JW, Lee JW, et al
    Combination of Helicobacter pylori infection and the interleukin 8 -251 T > A polymorphism, but not the mannose-binding lectin 2 codon 54 G > A polymorphism, might be a risk factor of gastric cancer.
    BMC Cancer. 2017;17:388.
    >> Share

  240. YOSHIZAWA J, Ishizone S, Ikeyama M, Nakayama J, et al
    Gastric hepatoid adenocarcinoma resulting in a spontaneous gastric perforation: a case report and review of the literature.
    BMC Cancer. 2017;17:368.
    >> Share

  241. JI X, Yan Y, Bu ZD, Li ZY, et al
    The optimal extent of gastrectomy for middle-third gastric cancer: distal subtotal gastrectomy is superior to total gastrectomy in short-term effect without sacrificing long-term survival.
    BMC Cancer. 2017;17:345.
    >> Share

    April 2017
  242. SAITO H, Fushida S, Miyashita T, Oyama K, et al
    Potential of extravasated platelet aggregation as a surrogate marker for overall survival in patients with advanced gastric cancer treated with preoperative docetaxel, cisplatin and S-1: a retrospective observational study.
    BMC Cancer. 2017;17:294.
    >> Share

  243. SHIN HB, An JY, Lee SH, Choi YY, et al
    Is adjuvant chemotherapy necessary in pT1N1 gastric cancer?
    BMC Cancer. 2017;17:287.
    >> Share

  244. KIM GM, Kim SJ, Song SK, Kim HR, et al
    Prevalence and prognostic implications of psychological distress in patients with gastric cancer.
    BMC Cancer. 2017;17:283.
    >> Share

  245. WU Z, Zhao J, Gao P, Song Y, et al
    Prognostic value of pretreatment standardized uptake value of F-18-fluorodeoxyglucose PET in patients with gastric cancer: a meta-analysis.
    BMC Cancer. 2017;17:275.
    >> Share

  246. XING X, Cai W, Ma S, Wang Y, et al
    Down-regulated expression of OPCML predicts an unfavorable prognosis and promotes disease progression in human gastric cancer.
    BMC Cancer. 2017;17:268.
    >> Share

    March 2017
  247. SHU P, Qin J, Shen K, Chen W, et al
    The IGCA staging system is more accurate than AJCC7 system in stratifying survival of patients with gastric cancer in stage III.
    BMC Cancer. 2017;17:238.
    >> Share

  248. WANG H, Lu J, Tang J, Chen S, et al
    Establishment of patient-derived gastric cancer xenografts: a useful tool for preclinical evaluation of targeted therapies involving alterations in HER-2, MET and FGFR2 signaling pathways.
    BMC Cancer. 2017;17:191.
    >> Share

  249. LIU X, Guo W, Zhang W, Yin J, et al
    A multi-center phase II study and biomarker analysis of combined cetuximab and modified FOLFIRI as second-line treatment in patients with metastatic gastric cancer.
    BMC Cancer. 2017;17:188.
    >> Share

  250. LEE JW, Choi MH, Lee YJ, Ali B, et al
    Radiofrequency ablation for liver metastases in patients with gastric cancer as an alternative to hepatic resection.
    BMC Cancer. 2017;17:185.
    >> Share

  251. HAMASHIMA C, Sasazuki S, Inoue M, Tsugane S, et al
    Receiver operating characteristic analysis of prediction for gastric cancer development using serum pepsinogen and Helicobacter pylori antibody tests.
    BMC Cancer. 2017;17:183.
    >> Share

    February 2017
  252. LUO Y, Chen J, Huang K, Lin Y, et al
    Early evaluation of sunitinib for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms via CT imaging: RECIST 1.1 or Choi Criteria?
    BMC Cancer. 2017;17:154.
    >> Share

  253. CHEN Z, Liang W
    Myopericytoma occurrence in the liver and stomach space: imaging performance.
    BMC Cancer. 2017;17:143.
    >> Share

  254. KOMAKI K, Kusaba T, Tanaka M, Kado H, et al
    Lower blood pressure and risk of cisplatin nephrotoxicity: a retrospective cohort study.
    BMC Cancer. 2017;17:144.
    >> Share

  255. LOZANO-POPE I, Sharma A, Matthias M, Doran KS, et al
    Effect of myeloid differentiation primary response gene 88 on expression profiles of genes during the development and progression of Helicobacter-induced gastric cancer.
    BMC Cancer. 2017;17:133.
    >> Share

  256. YU B, Chen X, Li J, Gu Q, et al
    microRNA-29c inhibits cell proliferation by targeting NASP in human gastric cancer.
    BMC Cancer. 2017;17:109.
    >> Share

    January 2017
  257. HUR H, Ham IH, Lee D, Jin H, et al
    Discoidin domain receptor 1 activity drives an aggressive phenotype in gastric carcinoma.
    BMC Cancer. 2017;17:87.
    >> Share

  258. RAO SV, Solum G, Niederdorfer B, Norsett KG, et al
    Gastrin activates autophagy and increases migration and survival of gastric adenocarcinoma cells.
    BMC Cancer. 2017;17:68.
    >> Share

  259. DIAO D, Cheng Y, Song Y, Zhang H, et al
    D-dimer is an essential accompaniment of circulating tumor cells in gastric cancer.
    BMC Cancer. 2017;17:56.
    >> Share

  260. LEE NK, Lee JH, Ivan C, Ling H, et al
    MALAT1 promoted invasiveness of gastric adenocarcinoma.
    BMC Cancer. 2017;17:46.
    >> Share

  261. OKAZAKI M, Fushida S, Harada S, Tsukada T, et al
    Establishing a xenograft mouse model of peritoneal dissemination of gastric cancer with organ invasion and fibrosis.
    BMC Cancer. 2017;17:23.
    >> Share

  262. SONG H, Fang F, Valdimarsdottir U, Lu D, et al
    Waiting time for cancer treatment and mental health among patients with newly diagnosed esophageal or gastric cancer: a nationwide cohort study.
    BMC Cancer. 2017;17:2.
    >> Share

    December 2016
  263. PU WY, Zhang R, Xiao L, Wu YY, et al
    Prediction of cancer progression in a group of 73 gastric cancer patients by circulating cell-free DNA.
    BMC Cancer. 2016;16:943.
    >> Share

  264. HOFHEINZ R, Clouth J, Borchardt-Wagner J, Wagner U, et al
    Patient preferences for palliative treatment of locally advanced or metastatic gastric cancer and adenocarcinoma of the gastroesophageal junction: a choice-based conjoint analysis study from Germany.
    BMC Cancer. 2016;16:937.
    >> Share

    November 2016
  265. SEO SH, Kim SE, Kang YK, Ryoo BY, et al
    Association of nutritional status-related indices and chemotherapy-induced adverse events in gastric cancer patients.
    BMC Cancer. 2016;16:900.
    >> Share

    October 2016
  266. FENG M, Yao G, Yu H, Qing Y, et al
    Tumor apelin, not serum apelin, is associated with the clinical features and prognosis of gastric cancer.
    BMC Cancer. 2016;16:794.
    >> Share

  267. JI X, Fu T, Bu ZD, Zhang J, et al
    Comparison of different methods of splenic hilar lymph node dissection for advanced upper- and/or middle-third gastric cancer.
    BMC Cancer. 2016;16:765.
    >> Share

    January 2016
  268. KUPCINSKAITE-NOREIKIENE R, Ugenskiene R, Noreika A, Rudzianskas V, et al
    Gene methylation profile of gastric cancerous tissue according to tumor site in the stomach.
    BMC Cancer. 2016;16:40.
    >> Share

  269. ZOU K, Yang S, Zheng L, Yang C, et al
    Efficacy and safety of target combined chemotherapy in advanced gastric cancer: a meta-analysis and system review.
    BMC Cancer. 2016;16:737.
    >> Share

  270. PARK WC, Kim HR, Kang DB, Ryu JS, et al
    Comparative expression patterns and diagnostic efficacies of SR splicing factors and HNRNPA1 in gastric and colorectal cancer.
    BMC Cancer. 2016;16:358.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016